Sepsis and Pathophysiology of Anthrax in a Nonhuman Primate Model
- 1 August 2006
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 169 (2) , 433-444
- https://doi.org/10.2353/ajpath.2006.051330
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1R01 AI058107, 1U19 AI062629, RR020143)
This publication has 74 references indexed in Scilit:
- iNOS-mediated nitric oxide production and its regulationLife Sciences, 2004
- Binding Stoichiometry and Kinetics of the Interaction of a Human Anthrax Toxin Receptor, CMG2, with Protective AntigenJournal of Biological Chemistry, 2004
- Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteriaNature, 2003
- PA63 Channel of Anthrax Toxin: An Extended β-BarrelBiochemistry, 2002
- Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United StatesEmerging Infectious Diseases, 2001
- Index Case of Fatal Inhalational Anthrax Due to Bioterrorism in the United StatesNew England Journal of Medicine, 2001
- Expression of LDL receptor-related protein/alpha 2-macroglobulin receptor in human normal and atherosclerotic arteries.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5Genomics, 1992
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.Journal of Clinical Investigation, 1987